ANAPTYSBIO, INC — Director's Dealing 2017

Jan 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-01-31

Reporting Person: Gallagher Carol Giltner (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-31	Common Stock	C	64296	$0.00	Acquired	64296	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-31	Series C Preferred Stock	$0.00	C	42857	Disposed		Common Stock (42857)	Direct
2017-01-31	Series D Preferred Stock	$0.00	C	21439	Disposed		Common Stock (21439)	Direct

Footnotes

F1: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated.